The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
AV

a.vermeulen

TL2 Moderator · Oulu

Contributes reviews on supplier material. Based in Oulu.

Joined 30 December 2024 · last posted 6d

86Posts here
0Topics
0Solutions
788Likes received
844Likes given
19Badges
196Days visited
3.3kPosts read

Most-liked posts

  • Journal club: LEADER as the historical anchor Replied, post #34 · Evidence › Journal club · 12 Feb 2026 · 33 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
  • Transit times by route, from a logged dataset — the long version Replied, post #71 · Sourcing › Logistics · 17 Mar 2025 · 33 likes On post #67 — agreed on the reasoning, with one qualification. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by…
  • Seven-day rolling means and why weekly readings mislead Replied, post #59 · Outcomes › Progress reports · 19 Jul 2026 · 28 likes post #58 is right about the mechanism and I think understates the practical bit. Medication changes: escalating dose, or adding or removing other medications, can…
  • Obstructive sleep apnoea and a hard endpoint in this class Replied, post #128 · Clinical › Comorbidities · 28 Jun 2025 · 28 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
  • Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #63 · Evidence › Journal club · 2 Jul 2026 · 27 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
  • A ten-fold dose error caught before injection — one year on Replied, post #124 · Devices › Syringes & needles · 4 Aug 2025 · 26 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

Where this member posts

CategoryPostsShare
Analytics1214%
Compounds1012%
Practice1012%
Sourcing89%
Clinical78%
Evidence67%

Badges earned, in order

BadgeTierGranted
Welcomebronze1 Jan 2025
Read the Guidelinesbronze2 Jan 2025
Basic Userbronze3 Jan 2025
First Replybronze5 Jan 2025
Asked Wellbronze7 Jan 2025
First Linkbronze18 Jan 2025
First Tagbronze25 Jan 2025
First Quotebronze7 Feb 2025
Memberbronze11 Feb 2025
Readerbronze11 Feb 2025
Generousbronze28 Feb 2025
Editorbronze6 Apr 2025
Sourcedbronze11 Apr 2025
Good Postsilver14 May 2025
Thank Yousilver21 May 2025
First Vendor Reportbronze12 Jul 2025
Nice Postbronze13 Jul 2025
De-escalatorgold23 Jul 2025
Anniversarysilver30 Dec 2025